Research Programs
UF Health Cancer Center Research Programs
The research priorities of the UF Health Cancer Center cut across and align with our three research programs.
Cancer Control & Population Sciences (CCPS)
Mission:
The mission of the Cancer Control & Population Sciences Research Program is to understand and reduce cancer risks and cancer-related burden within the UFHCC catchment area.
Program Co-Leaders:
Membership:
96 members from 10 colleges and 35 departments
Program Aims:
- Cancer Etiology: Elucidate causal factors in carcinogenesis and early detection
- Cancer Prevention: Develop and implement evidence-based primary and secondary cancer prevention interventions to reduce the cancer burden in our catchment area
- Cancer Survivorship: Address critical issues in cancer care delivery and survivorship care, especially in our older population
Working Group(s):
- Tobacco Control Working Group
- Supportive and Palliative Care Work Group
- Health Disparities Working Group
- Cancer Communication and Technology Working Group
Cancer Therapeutics & Host Response (CTHR)
Mission:
The mission of the Cancer Therapeutics & Host Response Research Program is to advance understanding of interactions between tumor cells, immune cells, and microbiota that mediate tumor development, progression and host responses, and to develop therapeutics that capitalize on these mechanisms and interactions.
Program Co-Leaders:
Membership:
132 members from eight colleges and 32 departments
Program Aims:
- Develop novel immunotherapies for refractory cancer
- Elucidate microbiome function in cancer development and therapeutics
- Identify and validate targeted therapeutics engaging key cancer pathways with small molecules and test new therapies in clinical trials
Mechanisms of Oncogenesis (MOO)
Mission:
The mission of the Mechanisms of Oncogenesis Research Program is to elucidate the genetic and epigenetic events dysregulated during neoplastic transformation and malignant progression to identify new cancer biomarkers and therapeutic targets.
Program Co-Leaders:
Membership:
58 members from seven colleges and 25 departments
Program Aims:
- Elucidate the role of genetic and epigenetic alterations in cancer
- Define the role of regulatory RNAs, including microRNAs and long noncoding RNAs in oncogenesis
- Translate MOO discoveries into novel diagnostic/prognostic biomarkers and therapeutic approaches
Working Group(s):
- DNA Damage Working Group
- Epigenetics and IncRNAs Seminar Series
- Viroholics Working Group
- Lung Cancer Research Group
